MeiraGTx Holdings (MGTX)

• Market cap: $619M
• 1 day: -0.52%
• 5 days: -0.78%
• 1 month: 0.92%
• 3 months: -5.67%
• 6 months: 4.37%
• Year to date: -2.05%
• 1 year: -2.8%
• 5 years: -56.61%
• 10 years: -49%
• Sector: Healthcare
• Industry: Biotechnology

About: MeiraGTx Holdings PLC is a clinical-stage gene therapy company. It focuses on the eye, salivary gland, and central nervous system disorders. The company's pipeline products include AAV-CNGB3, AAV-CNGA3 and AAV-RPGR, and others. Geographically, it operates in the United States, the United Kingdom, and European Union.

Employees: 409